Circassia Pharmaceuticals PLC (GB:NIOX)

LSE:NIOX

NIOX

Circassia Pharmaceuticals

RESEARCH TOOLSreports

Want to see GB:NIOX full AI Analyst Report?

Circassia Pharmaceuticals (NIOX) Price & Analysis

14 Followers

NIOX Stock Chart & Stats

68.00 p

-1.40 p(-2.28%)

At close: Jan 08 4:00 PM EST

68.00 p

-1.40 p(-2.28%)

Day’s Range― - ―

52-Week Range53.84 p - 77.60 p

Previous CloseN/A

Volume260.54K

Average Volume (3M)773.67K

Market Cap

£251.68M

Enterprise Value220.90M

Total Cash (Recent Filing)£19.90M

Total Debt (Recent Filing)£1.00M

Price to Earnings (P/E)36.1

Beta0.40

Next Earnings

Sep 10, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield3.4%

Share Statistics

EPS (TTM)0.01

Shares Outstanding420,866,300

10 Day Avg. Volume814,266

30 Day Avg. Volume773,666

Financial Highlights & Ratios

PEG Ratio0.43

Price to Book (P/B)3.73

Price to Sales (P/S)5.65

P/FCF Ratio17.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.03

Revenue Forecast (FY)£50.37M

Bulls Say, Bears Say

Bulls Say

Acquisition InterestNIOX has announced it has received a possible 81p/share all-cash offer from Keensight Capital valuing the business at £322m.

Market CompetitionThere also appear to be other counterparties considering an offer for the business so competing bids may yet emerge.

Shareholder ValueThe offer represents good value for shareholders for a single-product business in this space.

Bears Say

Acquisition UncertaintyDiscussions are early stages with no formal offer as yet from Keensight.

Macroeconomic EnvironmentKeensight Capital has announced that it does not intend to make a firm offer for the business at this stage due to the current uncertain macroeconomic environment.

Share Price VolatilityA level of weakness in the share price is anticipated due to recent newsflow and share price action related to it.

Circassia Pharmaceuticals News

NIOX Updates Total Voting Rights After Employee Option Exercises

The latest update is out from Circassia Pharmaceuticals ( ($GB:NIOX) ). NIOX Group plc has reported that, as...

8d ago

NIOX CFO reshuffles stake with modest share sales and ISA transfers

Circassia Pharmaceuticals ( ($GB:NIOX) ) has issued an announcement. NIOX Group plc disclosed a series of share transactions...

11d ago

NIOX Group Wins Full Shareholder Backing at 2026 AGM

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an announcement. NIOX Group plc reported that all resolutions proposed at...

19d ago

NIOX Secures Long-Term Sensor Supply as 2026 Trading Tracks Expectations

Circassia Pharmaceuticals ( ($GB:NIOX) ) has provided an update. NIOX Group reported that trading so far in 2026...

19d ago

NIOX Launches 2026 Employee Share Save Scheme With Discounted Options

Circassia Pharmaceuticals ( ($GB:NIOX) ) has provided an announcement. NIOX Group plc has launched its 2026 Save As...

1M ago

NIOX Group Updates Share Capital and Total Voting Rights

Circassia Pharmaceuticals ( ($GB:NIOX) ) has provided an announcement. NIOX Group has confirmed that its issued share capital...

1M ago

NIOX Group Sets Timetable for 2025 Final Dividend

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an update. NIOX Group plc has announced the timetable for its...

2M ago

NIOX CEO Reshapes Shareholdings With ISA Transfers

An announcement from Circassia Pharmaceuticals ( ($GB:NIOX) ) is now available. NIOX Group plc reported that chief executive...

2M ago

NIOX Group Sets Date and Details for 2026 Annual General Meeting

Circassia Pharmaceuticals ( ($GB:NIOX) ) has shared an update. NIOX Group plc has published the notice for its...

2M ago

NIOX Directors Exercise Options as Share Capital Rises

Circassia Pharmaceuticals ( ($GB:NIOX) ) just unveiled an announcement. NIOX Group plc has issued 1,466,320 new ordinary shares...

2M ago

Niox Group price target lowered to 86 GBp from 90 GBp at Deutsche Bank

Deutsche Bank analyst Kane Slutzkin lowered the firm’s price target on Niox Group (CSSPF) to 86 GBp from...

5M ago

Niox Group upgraded to Buy from Hold at Panmure Liberum

Panmure Liberum upgraded Niox Group (CSSPF) to Buy from Hold with a 69 GBp price target Published first...

1y ago

NIOX FAQ

What was Circassia Pharmaceuticals PLC’s price range in the past 12 months?

Circassia Pharmaceuticals PLC lowest share price was 53.84 p and its highest was 77.60 p in the past 12 months.

What is Circassia Pharmaceuticals PLC’s market cap?

Circassia Pharmaceuticals PLC’s market cap is £251.68M.

When is Circassia Pharmaceuticals PLC’s upcoming earnings report date?

Circassia Pharmaceuticals PLC’s upcoming earnings report date is Sep 10, 2026 which is in 93 days.

How were Circassia Pharmaceuticals PLC’s earnings last quarter?

Circassia Pharmaceuticals PLC released its earnings results on Mar 24, 2026. The company reported 0.003 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.003 p.

Is Circassia Pharmaceuticals PLC overvalued?

According to Wall Street analysts Circassia Pharmaceuticals PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Circassia Pharmaceuticals PLC pay dividends?

Circassia Pharmaceuticals PLC pays a Annually dividend of 1.55 p which represents an annual dividend yield of 3.4%. See more information on Circassia Pharmaceuticals PLC dividends here

What is Circassia Pharmaceuticals PLC’s EPS estimate?

Circassia Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Circassia Pharmaceuticals PLC have?

Circassia Pharmaceuticals PLC has 420,866,300 shares outstanding.

What happened to Circassia Pharmaceuticals PLC’s price movement after its last earnings report?

Circassia Pharmaceuticals PLC reported an EPS of 0.003 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.455%.

Which hedge fund is a major shareholder of Circassia Pharmaceuticals PLC?

Currently, no hedge funds are holding shares in GB:NIOX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Circassia Pharmaceuticals Stock Smart Score

Underperform

Insider Transactions

Sold Shares

Worth £276.3K over
the Last 3 Months

Technicals

Fundamentals

Return on Equity

10.14%

Trailing 12-Months

Asset Growth

11.40%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Circassia Pharmaceuticals PLC

NIOX Group Plc is a worldwide company dedicated to innovating, developing, and distributing medical devices that measure fractional exhaled nitric oxide (FeNO). A key product is the NIOX VERO system, an easily portable and non-invasive diagnostic tool designed for immediate, on-site patient use. This system includes a compact device alongside a suite of disposable items like sensors, individual mouthpieces, and breathing handles, all essential for quantifying FeNO levels in patients. The company, which was founded in 2006 and is headquartered in Oxford, United Kingdom, was formerly known as Circassia Group Plc until its renaming to NIOX Group Plc in September 2022.